| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | behavior | CACNA1C MCHR1 CPEB3 HIPK2 SYNPO SYNGAP1 SYNJ1 ABI2 RAPGEF3 AUTS2 KMT2A KCNQ3 CLDN5 PAX5 TBR1 SDK1 BAHCC1 | 3.02e-05 | 891 | 126 | 17 | GO:0007610 |
| GeneOntologyBiologicalProcess | zonula adherens assembly | 3.70e-05 | 2 | 126 | 2 | GO:0045186 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | EPS8L2 MYO9A SIPA1L3 IQSEC2 CRK SYNGAP1 DENND4B AUTS2 ROBO1 MCF2L | 3.87e-05 | 333 | 126 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | dendrite development | 4.07e-05 | 335 | 126 | 10 | GO:0016358 | |
| GeneOntologyBiologicalProcess | learning | 4.85e-05 | 212 | 126 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | cognition | CACNA1C CPEB3 SYNPO SYNGAP1 SYNJ1 ABI2 RAPGEF3 KMT2A CLDN5 TBR1 DOP1B | 5.82e-05 | 423 | 126 | 11 | GO:0050890 |
| GeneOntologyBiologicalProcess | learning or memory | CACNA1C CPEB3 SYNPO SYNGAP1 SYNJ1 ABI2 RAPGEF3 KMT2A CLDN5 TBR1 | 9.95e-05 | 373 | 126 | 10 | GO:0007611 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | EPS8L2 MYO9A SIPA1L3 IQSEC2 CRK SYNGAP1 ABI2 RAPGEF3 DENND4B AUTS2 ROBO1 MCF2L | 1.15e-04 | 538 | 126 | 12 | GO:0007264 |
| GeneOntologyBiologicalProcess | associative learning | 1.48e-04 | 130 | 126 | 6 | GO:0008306 | |
| GeneOntologyBiologicalProcess | cell junction assembly | DLG5 MYO9A MARK1 IQSEC2 CPEB3 NFASC CRK ABI2 ROBO1 CLDN5 TNS1 SDK1 | 1.94e-04 | 569 | 126 | 12 | GO:0034329 |
| GeneOntologyCellularComponent | cell-cell junction | DLG5 SIPA1L3 NFASC SYNPO YBX3 HEPACAM FNDC1 FAT1 LDB3 FAT2 ABI2 AJM1 CLDN5 | 5.03e-05 | 591 | 124 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | axon | TANC2 CACNA1C ZC3H14 MYO9A NFASC SYNPO HEPACAM SYNJ1 RAPGEF3 AUTS2 KCNQ3 ROBO1 CCDC120 CLDN5 USH2A | 2.59e-04 | 891 | 124 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | dendrite | TANC2 CACNA1C ZC3H14 MARK1 MARK3 CPEB3 NFASC SYNPO PALMD SYNGAP1 ABI2 RAB3IP KCNQ3 ROBO1 | 5.73e-04 | 858 | 124 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 CACNA1C ZC3H14 MARK1 MARK3 CPEB3 NFASC SYNPO PALMD SYNGAP1 ABI2 RAB3IP KCNQ3 ROBO1 | 5.86e-04 | 860 | 124 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO9A SIPA1L3 SYNPO LMOD2 CIT CRK LDB3 ABI2 RAPGEF3 AUTS2 CLDN5 | 6.44e-04 | 576 | 124 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | anchoring junction | DLG5 SIPA1L3 NFASC SYNPO YBX3 MAST2 HEPACAM FNDC1 FAT1 LDB3 FAT2 ABI2 AJM1 CLDN5 TNS1 | 6.73e-04 | 976 | 124 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 CACNA1C ZC3H14 MARK1 MARK3 CPEB3 NFASC SYNPO PALMD CIT SYNGAP1 ABI2 RAPGEF3 RAB3IP KCNQ3 ROBO1 USH2A | 9.41e-04 | 1228 | 124 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear speck | 1.09e-03 | 431 | 124 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 1.22e-03 | 9 | 124 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | tight junction | 1.45e-03 | 139 | 124 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 1.52e-03 | 10 | 124 | 2 | GO:0120103 | |
| MousePheno | postnatal lethality | TET2 CACNA1C MYO9A MARK3 CYP24A1 NFASC TAB2 SLFN14 LMOD2 CIT SYNGAP1 RIF1 FAT1 LDB3 SYNJ1 GLI2 NRK DCHS1 PAX5 TBR1 RAI1 | 1.85e-05 | 1084 | 99 | 21 | MP:0002082 |
| Domain | - | EPS8L2 IQSEC2 PLEKHA4 PLEKHG2 PLEKHA6 CIT GAB2 SYNGAP1 MCF2L TNS1 | 2.48e-04 | 391 | 122 | 10 | 2.30.29.30 |
| Domain | MARK/par1 | 2.52e-04 | 4 | 122 | 2 | IPR033624 | |
| Domain | KA1 | 4.18e-04 | 5 | 122 | 2 | PF02149 | |
| Domain | KA1_dom | 4.18e-04 | 5 | 122 | 2 | IPR001772 | |
| Domain | KA1 | 4.18e-04 | 5 | 122 | 2 | PS50032 | |
| Domain | - | 4.18e-04 | 5 | 122 | 2 | 3.30.310.80 | |
| Domain | PH | 4.85e-04 | 278 | 122 | 8 | SM00233 | |
| Domain | PH_dom-like | EPS8L2 IQSEC2 PLEKHA4 PLEKHG2 PLEKHA6 CIT GAB2 SYNGAP1 MCF2L TNS1 | 4.87e-04 | 426 | 122 | 10 | IPR011993 |
| Domain | PH_DOMAIN | 4.97e-04 | 279 | 122 | 8 | PS50003 | |
| Domain | PH_domain | 5.09e-04 | 280 | 122 | 8 | IPR001849 | |
| Domain | fn3 | 6.85e-04 | 162 | 122 | 6 | PF00041 | |
| Domain | PH | 7.72e-04 | 229 | 122 | 7 | PF00169 | |
| Pathway | REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM | 5.20e-05 | 13 | 82 | 3 | MM15210 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TET2 SLAIN2 DLG5 MYO9A MARK3 SIPA1L3 IQSEC2 LARP1 TAB2 PLEKHG2 MAST2 GAB2 C6orf132 SYNJ1 CASKIN2 STARD9 KMT2A SRRM2 DOP1B | 1.37e-10 | 861 | 134 | 20 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 CDK12 SIPA1L3 MYOM3 MAST2 CIT C6orf132 CCDC142 HIVEP3 PRR12 HEYL FAT1 SYNJ1 IL17RE HELZ2 DTX2 MCF2L SMURF2 SOWAHB RAI1 BAHCC1 | 1.68e-09 | 1105 | 134 | 21 | 35748872 |
| Pubmed | TET2 SLAIN2 DLG5 CDK12 SMCHD1 NACA PHRF1 LARP1 NFASC SYNPO KIAA1614 SEMA5B CASKIN2 AUTS2 RAI1 | 2.31e-09 | 529 | 134 | 15 | 14621295 | |
| Pubmed | Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing. | 6.48e-09 | 18 | 134 | 5 | 30111840 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | TANC2 MARK1 CDK12 ZC3H13 LARP1 SYNPO PRR12 RIF1 SNW1 STARD9 SRRM2 NUP153 | 1.77e-08 | 361 | 134 | 12 | 30344098 |
| Pubmed | HMBOX1 TET2 SMCHD1 NACA HIPK2 LARP1 MRPS35 YBX3 CIT IKZF5 PRR12 RIF1 FAT1 ZZZ3 SNW1 ATXN2 GLI2 AUTS2 KMT2A TBR1 SRRM2 SAP130 | 2.97e-08 | 1429 | 134 | 22 | 35140242 | |
| Pubmed | TANC2 CACNA1C CPEB3 SYNPO PLEKHA6 CIT SYNGAP1 SYNJ1 AJM1 RAB3IP SRRM2 | 1.15e-07 | 347 | 134 | 11 | 17114649 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 CDK12 ZC3H13 SMCHD1 LARP1 YBX3 WAC RIF1 ZZZ3 SNW1 ATXN2 BAZ1A KMT2A SRRM2 SAP130 NUP153 RAI1 | 1.71e-07 | 954 | 134 | 17 | 36373674 |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 2.17e-07 | 108 | 134 | 7 | 19531213 | |
| Pubmed | TET2 SLAIN2 ZC3H14 SMCHD1 LARP1 CIT IKZF5 WAC PRR12 SNW1 ATXN2 PPP4R2 KIAA1958 KMT2A SRRM2 SAP130 NUP153 RAI1 | 2.63e-07 | 1103 | 134 | 18 | 34189442 | |
| Pubmed | TANC2 MARK1 SIPA1L3 PLEKHA6 WAC HIVEP3 PRR12 PWWP2A LDB3 FAT2 HELZ2 DTX2 | 5.09e-07 | 493 | 134 | 12 | 15368895 | |
| Pubmed | 9.96e-07 | 85 | 134 | 6 | 23055939 | ||
| Pubmed | TANC2 SIPA1L3 IQSEC2 NFASC SYNPO CIT SYNGAP1 SNW1 SYNJ1 ATXN2 ABI2 RAB3IP DCHS1 TNS1 NUP153 RAI1 | 1.02e-06 | 963 | 134 | 16 | 28671696 | |
| Pubmed | SLAIN2 ZC3H14 DLG5 CDK12 MARK3 SIPA1L3 NACA PHRF1 MRPS35 ANKZF1 CIT C6orf132 PRR12 PWWP2A RIF1 ATXN2 ABI2 BAZ1A HELZ2 KMT2A | 1.25e-06 | 1497 | 134 | 20 | 31527615 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.39e-06 | 358 | 134 | 10 | 32460013 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CDK12 ZC3H13 SMCHD1 SIPA1L3 YBX3 MAST2 FAT1 BAZ1A SRRM2 NUP153 | 1.50e-06 | 361 | 134 | 10 | 26167880 |
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 16059920 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 EPS8L2 MARK3 SIPA1L3 LARP1 PLEKHA6 NLRP2 CRK C6orf132 SYNJ1 CASKIN2 CCDC120 | 2.10e-06 | 565 | 134 | 12 | 25468996 |
| Pubmed | 2.81e-06 | 225 | 134 | 8 | 12168954 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ZC3H14 MARK1 ZC3H13 SMCHD1 SIPA1L3 LARP1 YBX3 GPC6 WAC SNW1 ATXN2 RAB3IP AUTS2 CCDC120 SRRM2 | 2.92e-06 | 922 | 134 | 15 | 27609421 |
| Pubmed | 3.08e-06 | 103 | 134 | 6 | 10819331 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.41e-06 | 231 | 134 | 8 | 16452087 | |
| Pubmed | TROAP CDK12 ZC3H13 LARP1 PLEKHA6 ANKZF1 WAC RIF1 TRAFD1 SRRM2 NUP153 | 4.32e-06 | 503 | 134 | 11 | 16964243 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HMBOX1 CACNA1C MYO9A MARK3 SIPA1L3 HIPK2 LARP1 NFASC SYNPO HIVEP3 ATXN2 GLI2 RAB3IP AUTS2 MCF2L SAP130 SMURF2 FAM162A RAI1 | 4.61e-06 | 1489 | 134 | 19 | 28611215 |
| Pubmed | ZC3H14 ZC3H13 SMCHD1 PHRF1 LARP1 RIF1 SNW1 HELZ2 KMT2A SRRM2 NUP153 RAI1 | 9.11e-06 | 653 | 134 | 12 | 22586326 | |
| Pubmed | SLAIN2 ZC3H14 CDK12 SMCHD1 LARP1 CRK ZZZ3 SNW1 SYNJ1 KMT2A SAP130 | 9.83e-06 | 549 | 134 | 11 | 38280479 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMBOX1 ZC3H14 ZC3H13 SMCHD1 PHRF1 WAC PRR12 PWWP2A RIF1 ZZZ3 SNW1 BAZ1A KMT2A SRRM2 SAP130 NUP153 RAI1 | 1.05e-05 | 1294 | 134 | 17 | 30804502 |
| Pubmed | 1.42e-05 | 281 | 134 | 8 | 24163370 | ||
| Pubmed | A novel protein with RNA-binding motifs interacts with ataxin-2. | 1.47e-05 | 2 | 134 | 2 | 10814712 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11471052 | ||
| Pubmed | ZC3H13 Accelerates Keloid Formation by Mediating N6-methyladenosine Modification of HIPK2. | 1.47e-05 | 2 | 134 | 2 | 37752292 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28949795 | ||
| Pubmed | PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia. | 1.47e-05 | 2 | 134 | 2 | 22578776 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23329999 | ||
| Pubmed | Discs large 5 is required for polarization of citron kinase in mitotic neural precursors. | 1.47e-05 | 2 | 134 | 2 | 20436275 | |
| Pubmed | Gab2 plays a carcinogenic role in ovarian cancer by regulating CrkII. | 1.47e-05 | 2 | 134 | 2 | 37085900 | |
| Pubmed | Abl-interactor 2 (ABI2): a novel MLL translocation partner in acute myeloid leukemia. | 1.47e-05 | 2 | 134 | 2 | 22304832 | |
| Pubmed | 1.91e-05 | 41 | 134 | 4 | 22147266 | ||
| Pubmed | 2.02e-05 | 486 | 134 | 10 | 20936779 | ||
| Pubmed | 2.26e-05 | 87 | 134 | 5 | 12465718 | ||
| Pubmed | 2.84e-05 | 506 | 134 | 10 | 30890647 | ||
| Pubmed | 2.86e-05 | 152 | 134 | 6 | 38360978 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ZC3H14 DLG5 MARK3 ZC3H13 SMCHD1 SIPA1L3 NACA LARP1 MRPS35 SYNPO YBX3 CIT SNW1 ATXN2 HELZ2 NUP153 | 2.86e-05 | 1257 | 134 | 16 | 36526897 |
| Pubmed | ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination. | 3.66e-05 | 17 | 134 | 3 | 26581405 | |
| Pubmed | TANC2 MYO9A MARK1 MARK3 SIPA1L3 IQSEC2 LARP1 NFASC SYNPO PLEKHA6 CIT SYNGAP1 SYNJ1 AJM1 KMT2A KCNQ3 TNS1 | 3.77e-05 | 1431 | 134 | 17 | 37142655 | |
| Pubmed | CACNA1C SMCHD1 SIPA1L3 CNTRL LPCAT4 LARP1 MRPS35 SYNPO YBX3 BAZ1A STARD9 KMT2A MCF2L DTHD1 SMURF2 RAI1 BAHCC1 | 4.15e-05 | 1442 | 134 | 17 | 35575683 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 37602378 | ||
| Pubmed | Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors. | 4.41e-05 | 3 | 134 | 2 | 25667483 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 25849321 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 4.41e-05 | 3 | 134 | 2 | 15744052 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21145462 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 32823238 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12646957 | ||
| Pubmed | A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. | 4.41e-05 | 3 | 134 | 2 | 26901816 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24735925 | ||
| Pubmed | 4.64e-05 | 101 | 134 | 5 | 10997877 | ||
| Pubmed | 4.64e-05 | 101 | 134 | 5 | 26949739 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDK12 ZC3H13 PHRF1 LARP1 YBX3 RIF1 TRAFD1 HELZ2 KIAA1958 KMT2A SRRM2 NUP153 | 4.81e-05 | 774 | 134 | 12 | 15302935 |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 4.86e-05 | 102 | 134 | 5 | 15778465 | |
| Pubmed | 4.86e-05 | 102 | 134 | 5 | 10231032 | ||
| Pubmed | 4.96e-05 | 335 | 134 | 8 | 15741177 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 5.35e-05 | 170 | 134 | 6 | 16159877 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.62e-05 | 341 | 134 | 8 | 32971831 | |
| Pubmed | TANC2 SLAIN2 ZC3H14 MYO9A NACA MRPS35 PLEKHG2 CRK RIF1 KMT2A ROBO1 MCF2L NUP153 | 5.68e-05 | 916 | 134 | 13 | 32203420 | |
| Pubmed | 5.79e-05 | 551 | 134 | 10 | 34728620 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | HMBOX1 CDK12 SMCHD1 TTLL5 MUC16 PLEKHA6 PRR12 FAT1 HELZ2 TNS1 | 5.88e-05 | 552 | 134 | 10 | 10737800 |
| Pubmed | 6.08e-05 | 20 | 134 | 3 | 33888907 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 6.60e-05 | 349 | 134 | 8 | 25665578 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.87e-05 | 351 | 134 | 8 | 38297188 | |
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 6.97e-05 | 110 | 134 | 5 | 26841866 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 7.40e-05 | 457 | 134 | 9 | 32344865 | |
| Pubmed | The LMO2 oncogene regulates DNA replication in hematopoietic cells. | 7.61e-05 | 58 | 134 | 4 | 26764384 | |
| Pubmed | DLG5 CDK12 MARK3 SMCHD1 SIPA1L3 NACA LARP1 YBX3 ANKZF1 RIF1 SNW1 ATXN2 BAZ1A STARD9 HELZ2 KMT2A | 7.99e-05 | 1371 | 134 | 16 | 36244648 | |
| Pubmed | 8.26e-05 | 114 | 134 | 5 | 31553912 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.28e-05 | 184 | 134 | 6 | 32908313 | |
| Pubmed | 8.52e-05 | 268 | 134 | 7 | 33640491 | ||
| Pubmed | Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants. | 8.80e-05 | 4 | 134 | 2 | 28213671 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 36469134 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 19546859 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 29785024 | ||
| Pubmed | TROAP CDK12 SMCHD1 NACA LARP1 MRPS35 YBX3 FNDC1 TRAFD1 ATXN2 PPP4R2 SRRM2 NUP153 | 1.02e-04 | 971 | 134 | 13 | 33306668 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ZC3H14 SIPA1L3 NACA LARP1 MRPS35 YBX3 SNW1 ATXN2 RBFOX1 TBR1 SRRM2 | 1.06e-04 | 714 | 134 | 11 | 28302793 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.19e-04 | 283 | 134 | 7 | 30585729 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SLAIN2 DLG5 MYO9A MARK1 MARK3 SIPA1L3 MAST2 CIT LOXL1 RBFOX1 HELZ2 | 1.32e-04 | 732 | 134 | 11 | 34732716 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.36e-04 | 289 | 134 | 7 | 23752268 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MXRA5 ZC3H13 IQSEC2 MYOM3 LARP1 NFASC ZZZ3 DENND4B TBR1 RAI1 DOP1B | 1.38e-04 | 736 | 134 | 11 | 29676528 |
| Pubmed | 1.42e-04 | 203 | 134 | 6 | 35012549 | ||
| Pubmed | Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. | 1.46e-04 | 5 | 134 | 2 | 19564422 | |
| Pubmed | 1.46e-04 | 5 | 134 | 2 | 9199196 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.65e-04 | 132 | 134 | 5 | 16944949 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 CDK12 MARK3 SMCHD1 NACA LARP1 YBX3 RIF1 SNW1 BAZ1A SAP130 | 1.80e-04 | 759 | 134 | 11 | 35915203 |
| Pubmed | Aberrant RNA methylation triggers recruitment of an alkylation repair complex. | 2.19e-04 | 6 | 134 | 2 | 34686315 | |
| Pubmed | Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. | 2.19e-04 | 6 | 134 | 2 | 23666762 | |
| Pubmed | 2.19e-04 | 6 | 134 | 2 | 26463840 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.30e-04 | 315 | 134 | 7 | 26777405 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 CDK12 SMCHD1 NACA LARP1 WAC RIF1 SNW1 SYNJ1 BAZ1A KMT2A NUP153 | 2.76e-04 | 934 | 134 | 12 | 33916271 |
| Pubmed | Bifurcating action of Smoothened in Hedgehog signaling is mediated by Dlg5. | 3.06e-04 | 7 | 134 | 2 | 25644602 | |
| Pubmed | 3.06e-04 | 7 | 134 | 2 | 18981215 | ||
| Pubmed | SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. | 3.06e-04 | 7 | 134 | 2 | 19818711 | |
| Pubmed | 3.07e-04 | 34 | 134 | 3 | 25631876 | ||
| Interaction | YWHAH interactions | TANC2 TET2 SLAIN2 ZC3H14 DLG5 MYO9A MARK1 MARK3 ZC3H13 SIPA1L3 CNTRL IQSEC2 PLEKHA4 LARP1 TAB2 PLEKHG2 MAST2 CRK GAB2 C6orf132 SYNGAP1 SYNJ1 ABI2 CASKIN2 STARD9 KMT2A SRRM2 DOP1B | 1.53e-10 | 1102 | 126 | 28 | int:YWHAH |
| Interaction | YWHAG interactions | TANC2 TET2 SLAIN2 DLG5 MYO9A MARK1 CDK12 MARK3 ZC3H13 SIPA1L3 IQSEC2 PLEKHA4 LARP1 TAB2 SYNPO PLEKHG2 MAST2 CRK GAB2 C6orf132 SYNGAP1 SYNJ1 CASKIN2 BAZ1A STARD9 KMT2A SRRM2 | 1.11e-08 | 1248 | 126 | 27 | int:YWHAG |
| Interaction | SFN interactions | TANC2 TET2 MYO9A MARK1 MARK3 SIPA1L3 LARP1 TAB2 MAST2 CRK GAB2 C6orf132 RAB3IP KMT2A DTX2 SRRM2 SAP130 | 1.49e-06 | 692 | 126 | 17 | int:SFN |
| Interaction | NUP50 interactions | ZC3H14 CDK12 NACA PLEKHA4 CIT SNW1 KMT2A DTX2 SRRM2 SAP130 NUP153 RAI1 | 1.57e-06 | 341 | 126 | 12 | int:NUP50 |
| Interaction | TIMM23B interactions | 2.46e-06 | 35 | 126 | 5 | int:TIMM23B | |
| Interaction | YWHAE interactions | TANC2 TET2 DLG5 MYO9A MARK1 CDK12 MARK3 SIPA1L3 IQSEC2 PLEKHA4 LARP1 TAB2 MAST2 ANKZF1 CRK GAB2 C6orf132 SYNGAP1 ABI2 RAB3IP KMT2A SRRM2 SAP130 | 2.93e-06 | 1256 | 126 | 23 | int:YWHAE |
| Interaction | SH3KBP1 interactions | SLAIN2 ZC3H14 SYNPO PALMD CRK SYNGAP1 SYNJ1 ATXN2 ABI2 CASKIN2 SRRM2 | 4.71e-06 | 315 | 126 | 11 | int:SH3KBP1 |
| Interaction | YWHAB interactions | TANC2 TET2 SLAIN2 DLG5 MYO9A MARK1 MARK3 SIPA1L3 IQSEC2 PLEKHA4 LARP1 MAST2 CRK GAB2 C6orf132 ABI2 STARD9 KMT2A SRRM2 SAP130 | 4.77e-06 | 1014 | 126 | 20 | int:YWHAB |
| Interaction | SIPA1L1 interactions | 1.39e-05 | 174 | 126 | 8 | int:SIPA1L1 | |
| Interaction | PABPC5 interactions | 3.12e-05 | 142 | 126 | 7 | int:PABPC5 | |
| Interaction | CKS1B interactions | 3.49e-05 | 98 | 126 | 6 | int:CKS1B | |
| Interaction | TOP3B interactions | TANC2 CDK12 SIPA1L3 MYOM3 PLEKHA4 MAST2 CIT C6orf132 CCDC142 HIVEP3 PRR12 HEYL FAT1 SYNJ1 ATXN2 IL17RE HELZ2 DTX2 MCF2L SMURF2 SOWAHB RAI1 BAHCC1 | 3.73e-05 | 1470 | 126 | 23 | int:TOP3B |
| Interaction | SMC5 interactions | ZC3H14 CDK12 ZC3H13 SMCHD1 PLEKHA4 LARP1 YBX3 WAC RIF1 ZZZ3 SNW1 ATXN2 BAZ1A KMT2A SRRM2 SAP130 NUP153 RAI1 | 5.01e-05 | 1000 | 126 | 18 | int:SMC5 |
| Interaction | PPP1CC interactions | TANC2 MARK1 CDK12 ZC3H13 PLEKHA4 LARP1 SYNPO CIT PRR12 RIF1 SNW1 STARD9 SRRM2 TNS1 NUP153 | 5.86e-05 | 738 | 126 | 15 | int:PPP1CC |
| Interaction | YWHAQ interactions | TANC2 TET2 DLG5 MYO9A MARK1 MARK3 ZC3H13 SIPA1L3 IQSEC2 PLEKHA4 LARP1 TAB2 MAST2 CRK GAB2 C6orf132 BAZ1A STARD9 KMT2A | 6.57e-05 | 1118 | 126 | 19 | int:YWHAQ |
| Interaction | YWHAZ interactions | TANC2 TET2 DLG5 MYO9A MARK1 MARK3 SIPA1L3 IQSEC2 PLEKHA4 LARP1 TAB2 SYNPO MAST2 CRK GAB2 C6orf132 SYNGAP1 ABI2 STARD9 KMT2A TNS1 | 6.67e-05 | 1319 | 126 | 21 | int:YWHAZ |
| Interaction | SRSF6 interactions | ZC3H14 CDK12 ZC3H13 PHRF1 PLEKHA4 LARP1 MRPS35 YBX3 CIT SNW1 KMT2A SRRM2 | 7.59e-05 | 503 | 126 | 12 | int:SRSF6 |
| Interaction | PLEC interactions | TET2 MXRA5 MYO9A CDK12 NACA PLEKHA4 SYNPO CIT CRK SNW1 SRRM2 | 8.27e-05 | 430 | 126 | 11 | int:PLEC |
| Interaction | MBD3 interactions | 1.01e-04 | 295 | 126 | 9 | int:MBD3 | |
| Interaction | ABLIM3 interactions | 1.01e-04 | 39 | 126 | 4 | int:ABLIM3 | |
| Interaction | ACTN2 interactions | 1.01e-04 | 171 | 126 | 7 | int:ACTN2 | |
| Interaction | LATS1 interactions | TET2 SLAIN2 DLG5 SIPA1L3 PHRF1 PLEKHA4 MAST2 RIF1 TBR1 SRRM2 SMURF2 | 1.01e-04 | 440 | 126 | 11 | int:LATS1 |
| Interaction | TLE3 interactions | 1.28e-04 | 376 | 126 | 10 | int:TLE3 | |
| Interaction | SH3PXD2A interactions | 1.54e-04 | 128 | 126 | 6 | int:SH3PXD2A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE11 SPDYE13 SPDYE15 AUTS2 SPDYE8 DTX2 SPDYE14 | 8.96e-09 | 271 | 135 | 10 | chr7q11 |
| Cytoband | 7q11.23 | 1.06e-05 | 97 | 135 | 5 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 4.23e-04 | 118 | 135 | 4 | chr5q33 | |
| GeneFamily | Cadherin related | 6.06e-05 | 17 | 83 | 3 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 9.41e-05 | 160 | 83 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.73e-04 | 161 | 83 | 5 | 593 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.33e-03 | 12 | 83 | 2 | 756 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.59e-03 | 206 | 83 | 5 | 682 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 4.13e-03 | 21 | 83 | 2 | 89 | |
| GeneFamily | PDZ domain containing | 5.28e-03 | 152 | 83 | 4 | 1220 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | TANC2 CACNA1C EPS8L2 ZC3H13 SIPA1L3 LARP1 PLEKHA6 BBS9 RAPGEF3 SRRM2 TNS1 RNF212B | 1.10e-06 | 417 | 129 | 12 | M39224 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.46e-06 | 300 | 129 | 10 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 CACNA1C MARK1 LPCAT4 CPEB3 NFASC PLEKHA6 HIVEP3 FAT2 SYNJ1 RBFOX1 AUTS2 KCNQ3 ROBO1 PAX5 MCF2L RAI1 DOP1B | 8.25e-06 | 1106 | 129 | 18 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CACNA1C MARK1 LPCAT4 CPEB3 NFASC PLEKHA6 MAST2 GAB2 HIVEP3 KCNQ3 ROBO1 MCF2L | 3.28e-05 | 584 | 129 | 12 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 4.37e-05 | 335 | 129 | 9 | M39065 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 4.93e-05 | 193 | 129 | 7 | M6730 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 5.41e-05 | 429 | 129 | 10 | M45694 | |
| Coexpression | HEVNER_CORTEX_ROSTRAL_CORTICAL_PLATE | 5.42e-05 | 42 | 129 | 4 | MM446 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 5.99e-05 | 199 | 129 | 7 | M8029 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP | 5.99e-05 | 199 | 129 | 7 | M8294 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 6.18e-05 | 200 | 129 | 7 | M78 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZC3H14 MARK3 SMCHD1 TAB2 MAST2 RIF1 FAT1 ZZZ3 SNW1 ATXN2 BAZ1A SMURF2 NUP153 DOP1B | 8.53e-05 | 856 | 129 | 14 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MARK1 CPEB3 NFASC PLEKHA6 HIVEP3 RBFOX1 AUTS2 ROBO1 PAX5 USH2A | 1.05e-04 | 465 | 129 | 10 | M39066 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.07e-04 | 466 | 129 | 10 | M13522 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 1.25e-04 | 20 | 129 | 3 | M48357 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | 1.35e-04 | 304 | 129 | 8 | M45711 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SLAIN2 MYO9A CMTM4 TTLL5 HIPK2 TAB2 PLEKHG2 MAST2 CIT KIAA1614 GAB2 WAC SYNGAP1 BAZ1A GLI2 SMURF2 | 1.72e-05 | 780 | 127 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.23e-08 | 186 | 131 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.30e-08 | 189 | 131 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-07 | 199 | 131 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.00e-07 | 149 | 131 | 7 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-07 | 159 | 131 | 7 | c9e093d7c1dca83f6546adaf3d874929e2cea612 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.23e-07 | 166 | 131 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-07 | 171 | 131 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.59e-07 | 177 | 131 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.95e-07 | 178 | 131 | 7 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-06 | 181 | 131 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.24e-06 | 184 | 131 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.24e-06 | 184 | 131 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-06 | 185 | 131 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 185 | 131 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 185 | 131 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 188 | 131 | 7 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 188 | 131 | 7 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 190 | 131 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 190 | 131 | 7 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-06 | 190 | 131 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.59e-06 | 191 | 131 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-06 | 192 | 131 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.77e-06 | 194 | 131 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 194 | 131 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.96e-06 | 197 | 131 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 198 | 131 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 199 | 131 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-06 | 143 | 131 | 6 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.97e-06 | 160 | 131 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.87e-06 | 163 | 131 | 6 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 168 | 131 | 6 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 170 | 131 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-05 | 173 | 131 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 175 | 131 | 6 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 175 | 131 | 6 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 177 | 131 | 6 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 178 | 131 | 6 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 178 | 131 | 6 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-05 | 178 | 131 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-05 | 179 | 131 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 179 | 131 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 179 | 131 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 180 | 131 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-05 | 181 | 131 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.61e-05 | 181 | 131 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 183 | 131 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.71e-05 | 183 | 131 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 183 | 131 | 6 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 184 | 131 | 6 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 184 | 131 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.76e-05 | 184 | 131 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 184 | 131 | 6 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-05 | 185 | 131 | 6 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 185 | 131 | 6 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.82e-05 | 185 | 131 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 185 | 131 | 6 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 186 | 131 | 6 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 186 | 131 | 6 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.88e-05 | 186 | 131 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.88e-05 | 186 | 131 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 186 | 131 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-05 | 187 | 131 | 6 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-05 | 187 | 131 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.93e-05 | 187 | 131 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.93e-05 | 187 | 131 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-05 | 187 | 131 | 6 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-05 | 187 | 131 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-05 | 187 | 131 | 6 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 131 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 188 | 131 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 131 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-05 | 188 | 131 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 189 | 131 | 6 | 0daa8efac08dca9525d2b8d421952068cab4eb50 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-05 | 189 | 131 | 6 | b9c16823e86b01b96bf96d38224a13b9c856d8ad | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-05 | 189 | 131 | 6 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 189 | 131 | 6 | b6bb4327b4560d07d2b728abcc5f144f428948a5 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.05e-05 | 189 | 131 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.11e-05 | 190 | 131 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.11e-05 | 190 | 131 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-05 | 190 | 131 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 190 | 131 | 6 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.11e-05 | 190 | 131 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-05 | 190 | 131 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 190 | 131 | 6 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 191 | 131 | 6 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-05 | 191 | 131 | 6 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 191 | 131 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.18e-05 | 191 | 131 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-05 | 191 | 131 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 192 | 131 | 6 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 192 | 131 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 192 | 131 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 192 | 131 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 1.35e-06 | 189 | 129 | 9 | 7074_DN | |
| Drug | U mL | 9.57e-06 | 24 | 129 | 4 | CID000151195 | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.36e-05 | 191 | 129 | 8 | 4454_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 1.64e-05 | 196 | 129 | 8 | 2005_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 4992_UP | |
| Disease | Neurodevelopmental Disorders | 5.14e-09 | 93 | 122 | 8 | C1535926 | |
| Disease | intraocular pressure measurement | 5.25e-05 | 509 | 122 | 10 | EFO_0004695 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 8.69e-05 | 21 | 122 | 3 | C1292769 | |
| Disease | Psychomotor Agitation | 1.01e-04 | 4 | 122 | 2 | C3887612 | |
| Disease | Smith-Magenis syndrome | 1.01e-04 | 4 | 122 | 2 | C0795864 | |
| Disease | Akathisia | 1.01e-04 | 4 | 122 | 2 | C0392156 | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 1.01e-04 | 4 | 122 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | CDK12 PHRF1 YBX3 GPC6 HIVEP3 LDB3 LOXL1 PPP4R2 RBFOX1 AUTS2 ROBO1 | 1.14e-04 | 673 | 122 | 11 | HP_0000539 |
| Disease | coronary artery disease | TET2 CEL CDK12 MARK3 TAB2 YBX3 FNDC1 ATXN2 LOXL1 RBFOX1 PAX5 MCF2L TNS1 SAP130 RAI1 | 1.25e-04 | 1194 | 122 | 15 | EFO_0001645 |
| Disease | blood nickel measurement | 1.45e-04 | 120 | 122 | 5 | EFO_0007583 | |
| Disease | interleukin-8 measurement | 2.85e-04 | 31 | 122 | 3 | EFO_0004811 | |
| Disease | Schizophrenia | CACNA1C MCHR1 NFASC PLEKHA6 LMOD2 SYNGAP1 ATXN2 AUTS2 KMT2A KCNQ3 CLDN5 RAI1 | 3.06e-04 | 883 | 122 | 12 | C0036341 |
| Disease | joint hypermobility measurement | 3.44e-04 | 33 | 122 | 3 | EFO_0007905 | |
| Disease | Burkitt Lymphoma | 4.46e-04 | 36 | 122 | 3 | C0006413 | |
| Disease | myeloid white cell count | TET2 DLG5 ZDHHC18 CEL MAST2 CIT KIAA1614 CRK HIVEP3 CELA3B ATXN2 DTHD1 | 5.19e-04 | 937 | 122 | 12 | EFO_0007988 |
| Disease | anemia (phenotype), response to ribavirin | 5.99e-04 | 9 | 122 | 2 | EFO_0004272, GO_1901559 | |
| Disease | cortical thickness | MARK3 MRPS35 MAST2 BBS9 KIAA1614 CRK STPG2 ATXN2 BAZ1A AUTS2 KMT2A ROBO1 TNS1 | 7.17e-04 | 1113 | 122 | 13 | EFO_0004840 |
| Disease | Autistic Disorder | 7.77e-04 | 261 | 122 | 6 | C0004352 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 8.62e-04 | 45 | 122 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | hematocrit | SLAIN2 CACNA1C MYO9A SYNPO PLEKHA6 MAST2 PRR12 PWWP2A FAT1 ATXN2 RAI1 BAHCC1 | 1.01e-03 | 1011 | 122 | 12 | EFO_0004348 |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | Epilepsy | 1.11e-03 | 109 | 122 | 4 | C0014544 | |
| Disease | large artery stroke | 1.27e-03 | 113 | 122 | 4 | EFO_0005524 | |
| Disease | risk-taking behaviour | TET2 CACNA1C MARK3 NFASC STPG2 HIVEP3 RBFOX1 AUTS2 SDK1 BAHCC1 | 1.30e-03 | 764 | 122 | 10 | EFO_0008579 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.63e-03 | 56 | 122 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.72e-03 | 15 | 122 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | alcohol consumption measurement | CACNA1C DLG5 CDK12 MARK3 LPCAT4 CIT STPG2 ZZZ3 ABI2 RBFOX1 AUTS2 SDK1 BAHCC1 | 1.92e-03 | 1242 | 122 | 13 | EFO_0007878 |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0008297 | |
| Disease | Limb Deformities, Congenital | 2.21e-03 | 17 | 122 | 2 | C0206762 | |
| Disease | wellbeing measurement | 2.37e-03 | 692 | 122 | 9 | EFO_0007869 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.63e-03 | 447 | 122 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | inflammatory bowel disease | 2.70e-03 | 449 | 122 | 7 | EFO_0003767 | |
| Disease | biological sex | 2.73e-03 | 230 | 122 | 5 | PATO_0000047 | |
| Disease | creatinine measurement | TET2 ZDHHC18 CEL CDK12 SIPA1L3 CYP24A1 NMRK2 MAST2 KIAA1614 GAB2 ZZZ3 | 2.84e-03 | 995 | 122 | 11 | EFO_0004518 |
| Disease | Alzheimer disease, age at onset | 3.09e-03 | 343 | 122 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | alkaline phosphatase measurement | TET2 DLG5 ZDHHC18 CEL CYP24A1 KIAA1614 WAC HIVEP3 TRAFD1 ATXN2 RAI1 | 3.30e-03 | 1015 | 122 | 11 | EFO_0004533 |
| Disease | pentachlorophenol measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 3.61e-03 | 74 | 122 | 3 | EFO_0007886 | |
| Disease | chronotype measurement | TANC2 ZC3H14 CPEB3 GPC6 SYNGAP1 RBFOX1 DCHS1 AUTS2 PAX5 BOLL | 3.68e-03 | 882 | 122 | 10 | EFO_0008328 |
| Disease | glaucoma | 3.89e-03 | 154 | 122 | 4 | MONDO_0005041 | |
| Disease | visceral adipose tissue measurement | 3.93e-03 | 481 | 122 | 7 | EFO_0004765 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPQPLRAYSGSTVAS | 296 | Q5U5X8 | |
| ETPTARRLYTASGPP | 61 | Q86X53 | |
| DVRPQSSRYLPPGTR | 1966 | Q9P281 | |
| PGSTSRRQSVSPPYK | 266 | Q9NYV4 | |
| YSASTPVRKPRPGQQ | 1171 | Q7Z7A1 | |
| VPLNNPTSAPRYGTV | 16 | Q8N9W6 | |
| PTSAPRYGTVIPNRI | 21 | Q8N9W6 | |
| PTTIYPTDRRTGRPF | 936 | C9J069 | |
| PPSAPSEYAGLVVRT | 541 | Q17RM4 | |
| PFATPTGYRPQDRTV | 466 | P19835 | |
| TSRSSPNKRGPPTYN | 1916 | O14578 | |
| GGSLPYRRPPSITSQ | 366 | Q9NYB9 | |
| PGRYPSRSQQSTPKT | 1291 | Q9NRL2 | |
| RVSHYIINSSGPRPP | 56 | P46108 | |
| YQGSRSITPRPVGIT | 141 | A8MTL3 | |
| PARSVGRSPSYSSTP | 346 | Q7Z5J4 | |
| VSELPTQPVYSSPRR | 76 | Q96QF0 | |
| SSVPGPQSYPIVTGR | 291 | Q02548 | |
| VRPISYTPSIPSDSR | 4251 | Q14517 | |
| SRVPEYISGTSPPSV | 6491 | Q8WXI7 | |
| FYRPTTPQRETVTPG | 266 | Q9NP74 | |
| VGTRGLAPRFNSPTY | 991 | Q96JQ0 | |
| LQSSRPSPSKRPYGA | 11 | Q6NXN4 | |
| VPESPNYRNTRTPRT | 771 | Q6PKG0 | |
| SSSGAITYRQQRPGP | 1016 | Q9H2X6 | |
| ASIRPSVYQPVPAST | 401 | O75112 | |
| YLRPPHTSRGTSQTP | 486 | Q643R3 | |
| PYNKPSLSGARSAPR | 246 | Q86UW9 | |
| RYQSGPNSLPPRAAT | 566 | Q99700 | |
| QRYSVRNSVSPPPTV | 461 | Q9Y3R5 | |
| LSTAVDSPGSQPPYR | 256 | Q5JU85 | |
| QATPPSSATTYVERP | 731 | O43525 | |
| VPPVYTVSQARGSSP | 401 | Q8NFR9 | |
| PRTGRSYPFPDGVVT | 236 | Q5VZ46 | |
| QRGTPSSSPYVSPRH | 381 | Q6P5Q4 | |
| YVPAGPQRSESSSRV | 61 | Q08397 | |
| VLYERPQPTPAFSSR | 396 | Q96HB5 | |
| PHSRSFTAPPVSGRY | 611 | Q96HB5 | |
| RQTPPPVSATSGTFR | 251 | Q6NT76 | |
| SPVSPGPVYRLVASD | 1256 | Q9NYQ8 | |
| SPYVRTPVVESARPN | 941 | Q8WXX7 | |
| IPSTPRYPRSVVGSE | 1276 | Q8TDM6 | |
| STAVYQRPLTPRTPA | 321 | Q9P1Y6 | |
| GVSSPAYPIPALRTA | 206 | Q9NQ87 | |
| RGAYSPRPPSISENV | 1021 | P10070 | |
| SNPRVLPGPFSYTVV | 196 | Q9NX02 | |
| RPSHSQRNYSPVAGP | 316 | Q9H5V7 | |
| TPTPARGTPRSQSFA | 846 | Q8WXE0 | |
| RSQPVSQPLTYESGP | 616 | Q9H6S3 | |
| VSYSRPTDRNPDGIP | 506 | Q3SYG4 | |
| PSERYRTSGAPPESN | 716 | O94856 | |
| TRYGSPINTFTVRPG | 1156 | Q5T0Z8 | |
| PYNPEERPTTAAGTS | 366 | Q9Y625 | |
| LPRPAGYPSTVSTVE | 1826 | Q13936 | |
| PRQPPRLVTSTAYTS | 21 | Q07973 | |
| RSPASPSQAPYAQRS | 191 | Q8NE35 | |
| PTVQDSRARPPYTVA | 561 | Q9H8Y5 | |
| LSAPQRPPGTTQNYR | 171 | A6NCJ1 | |
| HSGVSRPVYRAESPP | 116 | Q4ZHG4 | |
| SGYGPPSSRPSSRVV | 16 | P08861 | |
| SRISLNYPPGVFTSP | 321 | Q6ZMT9 | |
| YRPGTTQRVPAASPS | 576 | Q9P0L2 | |
| ERRSVAYNGPPASPS | 621 | Q9P0L2 | |
| ERRTATYNGPPASPS | 571 | P27448 | |
| KRPGSNSYSSPQRPN | 11 | O15068 | |
| LSPRSPTQGYRVTPD | 1271 | Q6P0Q8 | |
| AGSPPRTGSISYINI | 96 | Q99705 | |
| SSQAEPYLERPSPTR | 921 | O75064 | |
| RTPSYSPTQRSPGCR | 2146 | Q03164 | |
| YPRSPARSPATGRTH | 361 | Q14CZ8 | |
| PVSAQSAFSYIPPRR | 21 | A4QMS7 | |
| RRRVYSAQGSSPPLP | 1796 | Q9BYK8 | |
| VNIVGPSPYSPSSRV | 1151 | Q7Z5N4 | |
| SYTERSNINGPGTPR | 161 | Q9NY27 | |
| PITRPAYQGSNPISD | 266 | Q8IWW8 | |
| RSTRNYTVPDPPGLF | 131 | Q9NPI5 | |
| PVTGRRSQSSPPYST | 846 | Q7Z2Y5 | |
| YPSTTLPVHRGPSRG | 491 | Q9UQC2 | |
| YVSSGPSVRNPRARV | 156 | P82673 | |
| SPTKATAPRYPQTGD | 401 | C9JL84 | |
| STPARNNAPGSPRYQ | 2456 | O75445 | |
| GRTVYNTFRAAAPPP | 276 | Q9NWB1 | |
| RYQNPSSGSLPPRVR | 461 | Q96N64 | |
| APPSVTRSPVENDGY | 231 | Q9UN30 | |
| SSTQSRPGEIPLRYP | 516 | P0C7P3 | |
| SGYVRPVPVPRSLNS | 216 | A6NHR9 | |
| PLSAYERVSGRTSPP | 2386 | Q9UQ35 | |
| PNDSPRSQIVPGARY | 411 | Q16650 | |
| SPARGIEYSRVSPQP | 366 | Q9P270 | |
| QPVRRSLPAPKTYGS | 556 | Q9P270 | |
| TYNQLSRSTSGPRPG | 461 | O14545 | |
| RPYITTPGGTTRQTQ | 216 | Q9NYJ8 | |
| YSTARPTIPPRAGVI | 1191 | O43426 | |
| VVRRDYSDSTNPGPP | 126 | P04053 | |
| PRNTTPYLPTSEGHR | 656 | Q9H4M7 | |
| TVAGTPPYPTSRRQT | 1206 | Q5UIP0 | |
| SERRPLGNFTAPPTY | 551 | Q8N3V7 | |
| PQEERSPQRSTSGYP | 16 | P0DUX0 | |
| PQEERSPQRSTSGYP | 16 | P0DTA3 | |
| PQEERSPQRSTSGYP | 16 | P0DUD1 | |
| ESITPGGRPPYRSNA | 1066 | O60292 | |
| VSPTQGGYPSEPTRS | 1826 | Q9HCD6 | |
| SPRSYVSPRISTPQT | 446 | Q9BTA9 | |
| TSSGGAPSRRQSYIP | 321 | Q9P2P6 | |
| GAYRSPSPQGTKAPR | 911 | Q9ULL5 | |
| IFPVYPLVGSSSPTR | 731 | A6NEL2 | |
| ESPGAPSRTYNRVPL | 46 | Q96A26 | |
| FPVKYSAPRRPTATG | 196 | O00501 | |
| PYQPTTEPVSQRRGL | 26 | Q8IZR5 | |
| ERPTRPASEYSSPGR | 186 | Q9HAU4 | |
| PRSHSVPRSPSQGSY | 451 | Q9Y2H5 | |
| VPRSPSQGSYSRARI | 456 | Q9Y2H5 | |
| SRPPTPGRNRYTVMS | 376 | O95398 | |
| ATSGPNQPSVRRGYR | 316 | P16989 | |
| EPSYGPARPRQQSLS | 1096 | Q96PV0 | |
| PQEERSPQRSTSGYP | 16 | A0A494C0Z2 | |
| PQEERSPQRSTSGYP | 16 | P0DUD3 | |
| PQEERSPQRSTSGYP | 16 | P0DUD4 | |
| PQEERSPQRSTSGYP | 16 | P0DUD2 | |
| SITPAPGTYNEPRTA | 211 | Q8N412 | |
| PTRYQVPSPSVRESS | 106 | Q8N7X2 | |
| TSPRIQPDYPAERSS | 441 | Q9H0E3 | |
| RASLESVPPGRSYSP | 781 | Q9HBL0 | |
| EGTTDPGLPRYSPTR | 2056 | Q5T1R4 | |
| FYTSRAPPSGPTRVC | 736 | Q12815 | |
| PPVRGAASSPAAVSY | 1241 | Q9Y6N7 | |
| QTSLVSSRREPPPYG | 31 | Q13573 | |
| YQRTRSCTSPAPSPG | 931 | Q9P283 | |
| AAQPTATSPVVYTRP | 626 | P49790 | |
| PQEERSPQRSTSGYP | 16 | A0A494C191 | |
| ARSFTPGRRNTAPSP | 456 | Q9H7P9 | |
| RPLETQGNPTSPRYN | 151 | Q5PR19 | |
| SASGSTNPYMRRPNP | 1561 | Q6N021 | |
| RRPNPVSPYPNSSHT | 1571 | Q6N021 | |
| GSSRPSIEIYRPPAS | 206 | Q6PJT7 | |
| APTRGSPTKNSSPYR | 386 | Q8IYH5 | |
| DNTGSSTYRPPPRTR | 166 | Q9NUE0 | |
| DPAQRASTRPIYPTF | 401 | Q6EMB2 | |
| YRNEGSPSPRQSPKR | 826 | Q5T200 | |
| PSETQTSPVERYPGR | 91 | Q8N8K9 | |
| TSEPTPVIYTRPGNT | 2736 | Q9NR99 | |
| TGASYPSQRSVIPPL | 346 | E9PAV3 | |
| RGNYPGPSSPVVVRL | 2286 | B2RTY4 | |
| RVPSPFGPREQSTYV | 346 | Q5VTT5 |